Position in DBVT
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$212,216
-$51,896 QoQ
Shares Held
12,940
+2.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#44
of 78 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 7%
Shared 0%
None 93%
Common Shares in DBVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PERSONAL CFO SOLUTIONS, LLC holds $4,413,711 across 7 Biotechnology names. DBVT ranks #7 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,692 | $1,055,029 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,120 | $1,053,067 | |
| 3 | INCY |
Incyte Corp
|
7,701 | $872,985 | |
| 4 | ABVX |
Abivax S.A.
|
3,313 | $441,490 | |
| 5 | EXEL |
Exelixis, Inc.
|
7,252 | $394,581 | |
| 6 | ASND |
Ascendis Pharma A/S
|
1,441 | $384,343 | |
| 7 | DBVT |
DBV Technologies S.A.
This page
|
12,940 | $212,216 |
All Filings in DBVT
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $212,216 | 12,940 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $264,112 | 12,643 | Shares | Sole | 2026-04-30 | |
| 2022-03-31 | $25,579 | 16,088 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $25,740 | 16,088 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $78,831 | 16,088 | Shares | Sole | 2021-11-18 | |
| 2021-06-30 | $87,840 | 16,088 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $123,059 | 23,088 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $50,010 | 19,088 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $44,267 | 25,588 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $121,111 | 27,588 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $108,144 | 27,588 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||